PICARD MEDICAL INC
PMINYSE AMERICANTrading Snapshot
- Day Range
- $6.10 β $6.79
- 52-Week Range
- $2.65 β $208.00
- Volume (shares)
- 20,274
- Avg Volume (shares)
- β
- Shares Outstanding
- 2.3M
- Next Earnings
- 2027-03-29
Fundamentals Snapshot
- Annual Revenue
- $5M
- Last Q Revenue
- $3M
- P/E Ratio
- β
- P/S Ratio
- 2.9x
- EPS (TTM)
- $-11.22
- Dividend Yield
- β
- Dilution (1yr)
- +2.3%
PICARD MEDICAL INC
PMIAbout PICARD MEDICAL INC
Picard Medical, Inc., through its associated companies, is dedicated to the entire process of medical device commercialization, from initial design and manufacturing to production, distribution, marketing, and sales. A key product in its portfolio is the SynCardia TAH, a sophisticated total artificial heart specifically engineered to supplant a failing human heart in individuals afflicted with advanced cardiac disease. The firm's market presence extends across the United States, Europe, and other international regions. Established in 2021, Picard Medical maintains its primary operations in Tucson, Arizona, functioning as a direct subsidiary of Hunniwell Picard I, Llc.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
Latest News & Updates

Perseverance Metals Commences Trading on the OTCQB Venture Market Under Symbol "PMIXF"
Vancouver, British Columbia--(Newsfile Corp. - November 18, 2026) - Perseverance Metals Inc.Β (TSXV: PMI) (OTCQB: PMIXF)Β ("Perseverance" or the "Company")Β is pleased to announce that its common shares have been approved f

Picard Medical Reports Third Quarter 2026 Financial Results; Gross Profit Positive for Third Consecutive Quarter; Net Loss Narrows 79% to $2.2 Million
Picard Medical Reports Third Quarter 2026 Financial Results; Gross Profit Positive for Third Consecutive Quarter; Net Loss Narrows 79% to $2.2 Million

18 Tax Changes to Understand Before December 31
The 2025 tax law is still unfolding, and 18 of its changes show up for the first time on 2026 returns. Meredith Margrave explains what's new, who it affects, and what to do before December 31.

Philip Morris International to Host Webcast of 2026 Third-Quarter and First Nine-Months Results
Regulatory News:Philip Morris International Inc. (PMI) (NYSE: PM) will host a live audio webcast on Wednesday, October 21, 2026, at 9:00 a.m. ET, to discuss its

Kuehn Law Encourages Investors of Picard Medical Inc. to Contact Law Firm
NEW YORK, Sept. 9, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Picard Medical Inc. (NYSE AMERICAN: PMI) Β breached their fiduciary du

PICARD MEDICAL INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Picard Medical, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Β Encourages Investors Who Suffered Losses In Picard (PMI) To Contact Him Directly To Discuss Their Options If you are a long-term stockholder inΒ Picard betwee